Career records & work history
License Records
John Grant Aunins
Address:
99 Pne Rdg Rd, Waban, MA 02468
Licenses:
License #: A2819613
Category: Airmen
Category: Airmen
John G Aunins, 6399 Pine Ridge Rd, Newton, MA 02468
John Aunins Phones & Addresses
99 Pine Ridge Rd, Waban, MA 02468 617-2433080
Center Sandwich, NH
Carnegie, OK
271 Oakland Ave, Doylestown, PA 18901 215-4897326
108 Kelsey Dr, Lansdale, PA 19446 215-3937326
Westfield, NJ
Cambridge, MA
Rahway, NJ
Mountainside, NJ
Buck, PA
271 W Oakland Ave, Doylestown, PA 18901 215-8800191
Social networks
John G Aunins
Linkedin
Work
Company:
Janis biologics Nov 2011
Position:
President
Education
Degree:
Doctorates, Doctor of Philosophy
School / High School:
Massachusetts Institute of Technology 1983 to 1989
Specialities:
Chemical Engineering
Skills
Vaccines • Cell Culture • Technology Transfer • Biotechnology • R&D • Fermentation • Biopharmaceuticals • Microbiology • Pharmaceutical Industry • Drug Development • Biologics • Lifesciences • Bioprocessing • Gmp • Fda • Sop • Drug Discovery • Validation • Life Sciences • Commercialization • Science • Protein Chemistry • Process Simulation • Molecular Biology • Clinical Development • Monoclonal Antibodies • Regulatory Affairs • Research and Development • Immunology • Clinical Research • Glp • Moxibustion • Abstract Expressionism • Ind • Stunts • Biochemistry • Good Laboratory Practice
Interests
Bioprocess R&D • Manufacturing Sciences • Viruses • Vaccines • Fermentation and Cell Culture
Emails
Industries
Biotechnology
Mentions for John G Aunins
John Aunins resumes & CV records
Resumes
Senior Advisor
Location:
99 Pine Ridge Rd, Waban, MA 02468
Industry:
Biotechnology
Work:
Janis Biologics
President Merck 1989 - 2011
Executive Director Proctor & Gamble 1982 - 1982
Intern Seres Therapeutics 1982 - 1982
Senior Advisor
President Merck 1989 - 2011
Executive Director Proctor & Gamble 1982 - 1982
Intern Seres Therapeutics 1982 - 1982
Senior Advisor
Education:
Massachusetts Institute of Technology 1983 - 1989
Doctorates, Doctor of Philosophy, Chemical Engineering The University of Kansas 1979 - 1983
Bachelors, Bachelor of Science, Chemical Engineering
Doctorates, Doctor of Philosophy, Chemical Engineering The University of Kansas 1979 - 1983
Bachelors, Bachelor of Science, Chemical Engineering
Skills:
Vaccines, Cell Culture, Technology Transfer, Biotechnology, R&D, Fermentation, Biopharmaceuticals, Microbiology, Pharmaceutical Industry, Drug Development, Biologics, Lifesciences, Bioprocessing, Gmp, Fda, Sop, Drug Discovery, Validation, Life Sciences, Commercialization, Science, Protein Chemistry, Process Simulation, Molecular Biology, Clinical Development, Monoclonal Antibodies, Regulatory Affairs, Research and Development, Immunology, Clinical Research, Glp, Moxibustion, Abstract Expressionism, Ind, Stunts, Biochemistry, Good Laboratory Practice
Interests:
Bioprocess R&D
Manufacturing Sciences
Viruses
Vaccines
Fermentation and Cell Culture
Manufacturing Sciences
Viruses
Vaccines
Fermentation and Cell Culture
Publications & IP owners
Us Patents
Large Scale Methods Of Producing Adenovirus And Adenovirus Seed Stocks
US Patent:
2005011, Jun 2, 2005
Filed:
Mar 27, 2003
Appl. No.:
10/509302
Inventors:
Weichang Zhou - Livermore CA, US
Liangzhi Xie - North Wales PA, US
Nedim Altaras - Harleysville PA, US
John Aunins - Doylestown PA, US
Liangzhi Xie - North Wales PA, US
Nedim Altaras - Harleysville PA, US
John Aunins - Doylestown PA, US
International Classification:
C12N007/02
US Classification:
435239000
Abstract:
A process for large scale virus production is disclosed, especially large scale adenovirus production. The methods described are preferably adapted to suspension culture of mammalian host cells in a large scale bioreactor where gas sparging becomes essential to provide adequate aeration through the duration of the culture. This methodology includes an elevated concentration of a compound which protects host cells from the shearing effects of gas sparging and agitation as well as utilizing virus seed stocks which have been generated free of cell lysis reagents. The invention also relates to methods of producing these virus seed stocks, which are scaleable and the resultant unclarified virus seed stocks which are concentrated to reduce storage volume for infection of large scale culture and which are free of cell lysis components, such as the detergent Triton X-100 or Polysorbate 80.
Synergistic Bacterial Compositions And Methods Of Production And Use Thereof
US Patent:
2022025, Aug 18, 2022
Filed:
Jan 28, 2022
Appl. No.:
17/588122
Inventors:
- Cambridge MA, US
Kevin Daniel LITCOFSKY - Boston MA, US
Anthony Mario D'ONOFRIO - Northborough MA, US
Toshiro K. OHSUMI - Cambridge MA, US
Mary-Jane Lombardo MCKENZIE - Arlington MA, US
Geoffrey VON MALTZAHN - Boston MA, US
David N. COOK - Brooklyn NY, US
David Arthur BERRY - Brookline MA, US
Noubar B. AFEYAN - Lexington MA, US
John Grant AUNINS - Doylestown PA, US
Kevin Daniel LITCOFSKY - Boston MA, US
Anthony Mario D'ONOFRIO - Northborough MA, US
Toshiro K. OHSUMI - Cambridge MA, US
Mary-Jane Lombardo MCKENZIE - Arlington MA, US
Geoffrey VON MALTZAHN - Boston MA, US
David N. COOK - Brooklyn NY, US
David Arthur BERRY - Brookline MA, US
Noubar B. AFEYAN - Lexington MA, US
John Grant AUNINS - Doylestown PA, US
Assignee:
Seres Therapeutics, Inc. - Cambridge MA
International Classification:
A61K 35/742
A61K 35/74
C12N 1/20
A23L 33/135
A61K 45/06
A61K 35/74
C12N 1/20
A23L 33/135
A61K 45/06
Abstract:
Provided are therapeutic compositions containing microbial populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
Compositions And Methods For Inhibition Of Pathogenic Bacterial Growth
US Patent:
2022024, Aug 11, 2022
Filed:
Nov 23, 2021
Appl. No.:
17/534361
Inventors:
- Cambridge MA, US
Han Zhang - Cambridge MA, US
Anthony Mario D'Onofrio - Northborough MA, US
David Arthur Berry - Brookline MA, US
Mary-Jane Lombardo McKenzie - Arlington MA, US
John Grant Aunins - Doylestown PA, US
Gregory McKenzie - Arlington MA, US
Toshiro K. Ohsumi - Cambridge MA, US
Han Zhang - Cambridge MA, US
Anthony Mario D'Onofrio - Northborough MA, US
David Arthur Berry - Brookline MA, US
Mary-Jane Lombardo McKenzie - Arlington MA, US
John Grant Aunins - Doylestown PA, US
Gregory McKenzie - Arlington MA, US
Toshiro K. Ohsumi - Cambridge MA, US
Assignee:
Seres Therapeutics, Inc. - Cambridge MA
International Classification:
A61K 35/741
A61K 9/00
A61K 45/06
A61K 9/48
C12N 1/20
A61K 35/74
A61K 35/742
A61K 35/744
A61K 35/745
A61K 35/747
A61K 35/37
A61K 9/00
A61K 45/06
A61K 9/48
C12N 1/20
A61K 35/74
A61K 35/742
A61K 35/744
A61K 35/745
A61K 35/747
A61K 35/37
Abstract:
Compositions for methods of preventing or reducing pathogenic bacterial growth, proliferation, and/or colonization are described containing one or more types of non-pathogenic bacteria to be introduced into the gastrointestinal tract and effectively compete with pathogenic bacteria for monomeric or polymeric carbohydrate nutrients, and/or amino acid nutrients, and/or vitamin nutrients.
Network-Based Microbial Compositions And Methods
US Patent:
2021025, Aug 19, 2021
Filed:
Jan 4, 2021
Appl. No.:
17/140385
Inventors:
- Cambridge MA, US
David N. COOK - Brookline MA, US
Toshiro K. OHSUMI - Cambridge MA, US
Mary-Jane Lombardo MCKENZIE - Arlington MA, US
Kevin D. LITCOFSKY - Boston MA, US
Han ZHANG - Oakton VA, US
John Grant AUNINS - Doylestown PA, US
David Arthur BERRY - Brookline MA, US
David N. COOK - Brookline MA, US
Toshiro K. OHSUMI - Cambridge MA, US
Mary-Jane Lombardo MCKENZIE - Arlington MA, US
Kevin D. LITCOFSKY - Boston MA, US
Han ZHANG - Oakton VA, US
John Grant AUNINS - Doylestown PA, US
David Arthur BERRY - Brookline MA, US
Assignee:
Seres Therapeutics, Inc, - Cambridge MA
International Classification:
A61K 35/742
A61K 35/74
A61K 35/741
A61K 35/745
A61K 35/74
A61K 35/741
A61K 35/745
Abstract:
Provided are therapeutic compositions containing combinations of bacteria, for the maintenance or restoration of a healthy microbiota in the gastrointestinal tract of a mammalian subject, and methods for use thereof.
Compositions And Methods
US Patent:
2021024, Aug 12, 2021
Filed:
Apr 5, 2021
Appl. No.:
17/222778
Inventors:
- Cambridge MA, US
Mary-Jane LOMBARDO MCKENZIE - Arlington MA, US
David N. COOK - Brooklyn NY, US
Marin VULIC - Boston MA, US
Geoffrey VON MALTZAHN - Boston MA, US
Brian GOODMAN - Boston MA, US
John Grant AUNINS - Doylestown PA, US
Matthew R. HENN - Somerville MA, US
David Arthur BERRY - Brookline MA, US
Jonathan WINKLER - Boston MA, US
Mary-Jane LOMBARDO MCKENZIE - Arlington MA, US
David N. COOK - Brooklyn NY, US
Marin VULIC - Boston MA, US
Geoffrey VON MALTZAHN - Boston MA, US
Brian GOODMAN - Boston MA, US
John Grant AUNINS - Doylestown PA, US
Matthew R. HENN - Somerville MA, US
David Arthur BERRY - Brookline MA, US
Jonathan WINKLER - Boston MA, US
Assignee:
Seres Therapeutics, Inc, - Cambridge MA
International Classification:
A61K 35/741
A61K 9/00
A61K 45/06
A61K 9/48
C12N 1/20
A61K 35/74
A61K 35/742
A61K 35/744
A61K 35/745
A61K 35/747
A61K 35/37
A61K 9/00
A61K 45/06
A61K 9/48
C12N 1/20
A61K 35/74
A61K 35/742
A61K 35/744
A61K 35/745
A61K 35/747
A61K 35/37
Abstract:
Disclosed herein are therapeutic compositions containing non-pathogenic, germination-competent bacterial spores, for the prevention, control, and treatment of gastrointestinal diseases, disorders and conditions and for general nutritional health.
Synergistic Bacterial Compositions And Methods Of Production And Use Thereof
US Patent:
2020034, Nov 5, 2020
Filed:
Dec 21, 2018
Appl. No.:
16/230807
Inventors:
- CAMBRIDGE MA, US
Kevin Daniel Litcofsky - Boston MA, US
Anthony Mario D'Onofrio - Northborough MA, US
Toshiro K. Ohsumi - Cambridge MA, US
Mary-Jane Lombardo McKenzie - Arlington MA, US
Geoffrey von Maltzahn - Boston MA, US
David N. Cook - Brooklyn NY, US
David Arthur Berry - Brookline MA, US
Noubar B. Afeyan - Lexington MA, US
John Grant Aunins - Doylestown PA, US
Kevin Daniel Litcofsky - Boston MA, US
Anthony Mario D'Onofrio - Northborough MA, US
Toshiro K. Ohsumi - Cambridge MA, US
Mary-Jane Lombardo McKenzie - Arlington MA, US
Geoffrey von Maltzahn - Boston MA, US
David N. Cook - Brooklyn NY, US
David Arthur Berry - Brookline MA, US
Noubar B. Afeyan - Lexington MA, US
John Grant Aunins - Doylestown PA, US
Assignee:
SERES THERAPEUTICS, INC. - CAMBRIDGE MA
International Classification:
A61K 35/742
A61K 35/74
C12N 1/20
A23L 33/135
A61K 45/06
A61K 35/74
C12N 1/20
A23L 33/135
A61K 45/06
Abstract:
Provided are therapeutic compositions containing microbial populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
Synergistic Bacterial Compositions And Methods Of Production And Use Thereof
US Patent:
2019035, Nov 21, 2019
Filed:
Dec 17, 2018
Appl. No.:
16/223008
Inventors:
- Cambridge MA, US
Geoffrey von Maltzahn - Boston MA, US
Anthony Mario D'Onofrio - Northborough MA, US
Kevin Daniel Litcofsky - Boston MA, US
David Arthur Berry - Brookline MA, US
David N. Cook - Brooklyn NY, US
Noubar B. Afeyan - Lexington MA, US
John Grant Aunins - Doylestown PA, US
Geoffrey von Maltzahn - Boston MA, US
Anthony Mario D'Onofrio - Northborough MA, US
Kevin Daniel Litcofsky - Boston MA, US
David Arthur Berry - Brookline MA, US
David N. Cook - Brooklyn NY, US
Noubar B. Afeyan - Lexington MA, US
John Grant Aunins - Doylestown PA, US
Assignee:
Seres Therapeutics, Inc. - Cambridge MA
International Classification:
A61K 35/742
A61K 35/74
A61K 9/00
A61K 9/48
A61K 45/06
A61K 38/13
A23L 33/135
A23P 10/30
A23L 33/10
A61K 35/74
A61K 9/00
A61K 9/48
A61K 45/06
A61K 38/13
A23L 33/135
A23P 10/30
A23L 33/10
Abstract:
Provided are therapeutic compositions containing Ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
Compositions And Methods
US Patent:
2019009, Apr 4, 2019
Filed:
Aug 3, 2018
Appl. No.:
16/054864
Inventors:
- Cambridge MA, US
Mary-Jane Lombardo McKenzie - Arlington MA, US
David N. Cook - Brooklyn NY, US
Marin Vulic - Boston MA, US
Geoffrey von Maltzahn - Boston MA, US
Brian Goodman - Boston MA, US
John Grant Aunins - Doylestown PA, US
Matthew R. Henn - Somerville MA, US
David Arthur Berry - Brookline MA, US
Jonathan Winkler - Boston MA, US
Mary-Jane Lombardo McKenzie - Arlington MA, US
David N. Cook - Brooklyn NY, US
Marin Vulic - Boston MA, US
Geoffrey von Maltzahn - Boston MA, US
Brian Goodman - Boston MA, US
John Grant Aunins - Doylestown PA, US
Matthew R. Henn - Somerville MA, US
David Arthur Berry - Brookline MA, US
Jonathan Winkler - Boston MA, US
International Classification:
A61K 35/741
A61K 45/06
A61K 35/742
A61K 9/48
A61K 35/747
A61K 35/745
A61K 35/744
C12N 1/20
A61K 35/74
A61K 35/37
A61K 9/00
A61K 45/06
A61K 35/742
A61K 9/48
A61K 35/747
A61K 35/745
A61K 35/744
C12N 1/20
A61K 35/74
A61K 35/37
A61K 9/00
Abstract:
Disclosed herein are therapeutic compositions containing non-pathogenic, germination-competent bacterial spores, for the prevention, control, and treatment of gastrointestinal diseases, disorders and conditions and for general nutritional health.
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.